Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × HIV Seropositivity × Electroporation Therapies × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Intraepithelial Lesions 1 Squamous Cell Carcinoma of Head and Neck 1 Pancreatic Neoplasms 1 Melanoma 1 HIV Seropositivity 1

Interventions

Vincristine 1 VGX-3100 1 Tobacco Use Cessation Devices 1 Surveys and Questionnaires 1 Rituximab 1 Prednisone 1 Etoposide 1 Electroporation Therapies 1 Electroporation 1 Drug Therapy 1 Doxorubicin 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03603808 2025-07-16

VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions

AIDS Malignancy Consortium

Phase 2 Completed

Squamous Intraepithelial Lesions, HIV Seropositivity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡